191 related articles for article (PubMed ID: 35249103)
1. METTL14-mediated N6-methyladenosine modification of Pten mRNA inhibits tumour progression in clear-cell renal cell carcinoma.
Zhang L; Luo X; Qiao S
Br J Cancer; 2022 Jul; 127(1):30-42. PubMed ID: 35249103
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
3. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
4. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
5. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
[TBL] [Abstract][Full Text] [Related]
6. The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.
Yao Q; He L; Gao X; Tang N; Lin L; Yu X; Wang D
Front Oncol; 2021; 11():699749. PubMed ID: 34476213
[TBL] [Abstract][Full Text] [Related]
7. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
[TBL] [Abstract][Full Text] [Related]
8. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
9. Analysis and verification of
Yang Z; Peng B; Pan Y; Gu Y
Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
[No Abstract] [Full Text] [Related]
10. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
11. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
[TBL] [Abstract][Full Text] [Related]
12. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
13. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
14. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
15. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
[TBL] [Abstract][Full Text] [Related]
16. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
Ren S; Xiao Y; Yang L; Hu Y
Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
[TBL] [Abstract][Full Text] [Related]
17. METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.
Cheng C; Zhang H; Zheng J; Jin Y; Wang D; Dai Z
Aging (Albany NY); 2021 Dec; 13(24):25903-25919. PubMed ID: 34910686
[TBL] [Abstract][Full Text] [Related]
18. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N
Yang L; Chen Y; Liu N; Shi Q; Han X; Gan W; Li D
J Hematol Oncol; 2021 Mar; 14(1):46. PubMed ID: 33741027
[TBL] [Abstract][Full Text] [Related]
19. Relevance and therapeutic possibility of PTEN-long in renal cell carcinoma.
Wang H; Zhang P; Lin C; Yu Q; Wu J; Wang L; Cui Y; Wang K; Gao Z; Li H
PLoS One; 2015; 10(2):e114250. PubMed ID: 25714556
[TBL] [Abstract][Full Text] [Related]
20. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]